163 related articles for article (PubMed ID: 20626559)
1. Involvement of threonine 258 and serine 259 motif in amphetamine-induced norepinephrine transporter endocytosis.
Annamalai B; Mannangatti P; Arapulisamy O; Ramamoorthy S; Jayanthi LD
J Neurochem; 2010 Oct; 115(1):23-35. PubMed ID: 20626559
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of the norepinephrine transporter at threonine 258 and serine 259 is linked to protein kinase C-mediated transporter internalization.
Jayanthi LD; Annamalai B; Samuvel DJ; Gether U; Ramamoorthy S
J Biol Chem; 2006 Aug; 281(33):23326-40. PubMed ID: 16740633
[TBL] [Abstract][Full Text] [Related]
3. Blunted Amphetamine-induced Reinforcing Behaviors and Transporter Downregulation in Knock-in Mice Carrying Alanine Mutations at Threonine-258 and Serine-259 of Norepinephrine Transporter.
Ragu Varman D; Mannangatti P; Subler MA; Windle JJ; Ramamoorthy S; Jayanthi LD
J Mol Neurosci; 2022 Sep; 72(9):1965-1976. PubMed ID: 35852782
[TBL] [Abstract][Full Text] [Related]
4. Amphetamine induces a calcium/calmodulin-dependent protein kinase II-dependent reduction in norepinephrine transporter surface expression linked to changes in syntaxin 1A/transporter complexes.
Dipace C; Sung U; Binda F; Blakely RD; Galli A
Mol Pharmacol; 2007 Jan; 71(1):230-9. PubMed ID: 17032905
[TBL] [Abstract][Full Text] [Related]
5. Interference of norepinephrine transporter trafficking motif attenuates amphetamine-induced locomotor hyperactivity and conditioned place preference.
Mannangatti P; Ramamoorthy S; Jayanthi LD
Neuropharmacology; 2018 Jan; 128():132-141. PubMed ID: 28986281
[TBL] [Abstract][Full Text] [Related]
6. Cocaine up-regulation of the norepinephrine transporter requires threonine 30 phosphorylation by p38 mitogen-activated protein kinase.
Mannangatti P; Arapulisamy O; Shippenberg TS; Ramamoorthy S; Jayanthi LD
J Biol Chem; 2011 Jun; 286(23):20239-50. PubMed ID: 21498515
[TBL] [Abstract][Full Text] [Related]
7. Regulated norepinephrine transporter interaction with the neurokinin-1 receptor establishes transporter subcellular localization.
Arapulisamy O; Mannangatti P; Jayanthi LD
J Biol Chem; 2013 Oct; 288(40):28599-610. PubMed ID: 23979140
[TBL] [Abstract][Full Text] [Related]
8. Amphetamine Stimulates Endocytosis of the Norepinephrine and Neuronal Glutamate Transporters in Cultured Locus Coeruleus Neurons.
Underhill SM; Colt MS; Amara SG
Neurochem Res; 2020 Jun; 45(6):1410-1419. PubMed ID: 31912366
[TBL] [Abstract][Full Text] [Related]
9. Rab11 supports amphetamine-stimulated norepinephrine transporter trafficking.
Matthies HJ; Moore JL; Saunders C; Matthies DS; Lapierre LA; Goldenring JR; Blakely RD; Galli A
J Neurosci; 2010 Jun; 30(23):7863-77. PubMed ID: 20534835
[TBL] [Abstract][Full Text] [Related]
10. Amphetamine-induced decreases in dopamine transporter surface expression are protein kinase C-independent.
Boudanova E; Navaroli DM; Melikian HE
Neuropharmacology; 2008 Mar; 54(3):605-12. PubMed ID: 18164041
[TBL] [Abstract][Full Text] [Related]
11. Regulated internalization and phosphorylation of the native norepinephrine transporter in response to phorbol esters. Evidence for localization in lipid rafts and lipid raft-mediated internalization.
Jayanthi LD; Samuvel DJ; Ramamoorthy S
J Biol Chem; 2004 Apr; 279(18):19315-26. PubMed ID: 14976208
[TBL] [Abstract][Full Text] [Related]
12. Neurokinin-1 Antagonism Distinguishes the Role of Norepinephrine Transporter from Dopamine Transporter in Mediating Amphetamine Behaviors.
Mannangatti P; Ragu Varman D; Ramamoorthy S; Jayanthi LD
Pharmacology; 2021; 106(11-12):597-605. PubMed ID: 34515205
[TBL] [Abstract][Full Text] [Related]
13. Site-directed mutations near transmembrane domain 1 alter conformation and function of norepinephrine and dopamine transporters.
Guptaroy B; Fraser R; Desai A; Zhang M; Gnegy ME
Mol Pharmacol; 2011 Mar; 79(3):520-32. PubMed ID: 21149640
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of the human norepinephrine transporter in intact 293-hNET cells exposed to desipramine.
Zhu MY; Blakely RD; Apparsundaram S; Ordway GA
J Neurochem; 1998 Apr; 70(4):1547-55. PubMed ID: 9523572
[TBL] [Abstract][Full Text] [Related]
15. Reserpine-induced reduction in norepinephrine transporter function requires catecholamine storage vesicles.
Mandela P; Chandley M; Xu YY; Zhu MY; Ordway GA
Neurochem Int; 2010; 56(6-7):760-7. PubMed ID: 20176067
[TBL] [Abstract][Full Text] [Related]
16. Amphetamine activates Rho GTPase signaling to mediate dopamine transporter internalization and acute behavioral effects of amphetamine.
Wheeler DS; Underhill SM; Stolz DB; Murdoch GH; Thiels E; Romero G; Amara SG
Proc Natl Acad Sci U S A; 2015 Dec; 112(51):E7138-47. PubMed ID: 26553986
[TBL] [Abstract][Full Text] [Related]
17. Repeated amphetamine treatment induces neurite outgrowth and enhanced amphetamine-stimulated dopamine release in rat pheochromocytoma cells (PC12 cells) via a protein kinase C- and mitogen activated protein kinase-dependent mechanism.
Park YH; Kantor L; Guptaroy B; Zhang M; Wang KK; Gnegy ME
J Neurochem; 2003 Dec; 87(6):1546-57. PubMed ID: 14713310
[TBL] [Abstract][Full Text] [Related]
18. Dopamine transporter activity mediates amphetamine-induced inhibition of Akt through a Ca2+/calmodulin-dependent kinase II-dependent mechanism.
Wei Y; Williams JM; Dipace C; Sung U; Javitch JA; Galli A; Saunders C
Mol Pharmacol; 2007 Mar; 71(3):835-42. PubMed ID: 17164407
[TBL] [Abstract][Full Text] [Related]
19. Amphetamine regulation of dopamine transport. Combined measurements of transporter currents and transporter imaging support the endocytosis of an active carrier.
Kahlig KM; Javitch JA; Galli A
J Biol Chem; 2004 Mar; 279(10):8966-75. PubMed ID: 14699142
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of CaMKII in the nucleus accumbens shell decreases enhanced amphetamine intake in sensitized rats.
Loweth JA; Baker LK; Guptaa T; Guillory AM; Vezina P
Neurosci Lett; 2008 Oct; 444(2):157-60. PubMed ID: 18694805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
